Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection

Journal of Virology

Volumn 88, Issue 13, 2014, Pages 7412-7425

  Clay, Candice C ^a   Rachel Reader, J ^a   Gerriets, Joan E ^a   Wang, Theodore T ^a   Harrod, Kevin S ^b   Miller, Lisa A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CASPASE 3; INTERFERON; MESSENGER RNA;

ADAPTIVE IMMUNITY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRONCHIOLITIS; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOMODULATION; INFANT; INFLUENZA A (H1N1); INNATE IMMUNITY; LUNG ALVEOLITIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN SYNTHESIS; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SIGNAL TRANSDUCTION; VIRAL CLEARANCE; VIRUS REPLICATION; VIRUS TITRATION; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; EPITHELIUM; GENETICS; IMMUNOLOGY; INFLAMMATION; INFLUENZA A VIRUS (H1N1); LUNG; NEWBORN; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM; VIROLOGY; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; IMMUNITY, INNATE; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERFERONS; LUNG; MACACA MULATTA; ORTHOMYXOVIRIDAE INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRUS REPLICATION;

EID: 84901981502     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00188-14     Document Type: Article

References (57)

1. Laraya-Cuasay LR, DeForest A, Huff D, Lischner H, Huang NN. 1977. Chronic pulmonary complications of early influenza virus infection in children. Am. Rev. Respir. Dis. 116:617-625.
2. Ajayi-Obe EK, Coen PG, Handa R, Hawrami K, Aitken C, McIntosh ED, Booy R. 2008. Influenza A and respiratory syncytial virus hospital burden in young children in East London. Epidemiol. Infect. 136:1046-1058. http://dx.doi.org/10.1017/S0950268807009557.
3. Myles PR, Semple MG, Lim WS, Openshaw PJ, Gadd EM, Read RC, Taylor BL, Brett SJ, McMenamin J, Enstone JE, Armstrong C, Bannister B, Nicholson KG, Nguyen-Van-Tam JS. 2012. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax 67:709-717. http: //dx.doi.org/10.1136/thoraxjnl-2011-200266.
4. Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, Cavalieri ML, Guglielmo MC, Areso MS, Gilligan T, Santucho F, Cabral G, Gregorio GL, Moreno R, Lutz MI, Panigasi AL, Saligari L, Caballero MT, Egues Almeida RM, Gutierrez Meyer ME, Neder MD, Davenport MC, Del Valle MP, Santidrian VS, Mosca G, Garcia Dominguez M, Alvarez L, Landa P, Pota A, Bolonati N, Dalamon R, Sanchez Mercol VI, Espinoza M, Peuchot JC, Karolinski A, Bruno M, Borsa A, Ferrero F, Bonina A, Ramonet M, Albano LC, Luedicke N, Alterman E, Savy V, Baumeister E, Chappell JD, Edwards KM, Melendi GA, Polack FP.2010. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N. Engl. J. Med. 362:45-55. http://dx.doi.org/10 .1056/NEJMoa0907673.
5. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. 2010. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 182:39-44. http://dx.doi.org/10.1503/cmaj .091724.
6. Shannon S, Louie J, Siniscalchi A, Rico E, Richter D, Hernandez R, Lynfield R, Stoute L, Landers K, Brady U, Pascoe N, Vernon V, Haupt T, Moore C, Schieve L, Peacock G, Boyle C, Finelli L, Uyeki T, Dhara R, Fowlkes A, Christensen D, Jarquin V, CDC. 2009. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection-United States April-August 2009. MMWR Morb. Mortal. Wkly. Rep. 58:941-947. http://www.cdc.gov/mmwr/preview/mmwrhtml /mm5834a1.htm.
7. Martic J, Savic N, Minic P, Pasic S, Nedeljkovic J, Jankovic B. 2011. Novel H1N1 influenza in neonates: from mild to fatal disease. J. Perinatol. 31:446-448. http://dx.doi.org/10.1038/jp.2010.194.
8. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL. 2009. Response to a monovalent 2009 influenza A (H1N1) vaccine. N. Engl. J. Med. 361:2405-2413. http://dx.doi.org/10.1056/NEJMoa0907413.
9. Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, Zhang XF, Pan HX, Meng FY, Hu YM, Liu WD, Li CG, Li W, Zhang X, Hu JM, Peng WB, Yang BP, Xi P, Wang HQ, Zheng JS. 2009. A novel influenza A (H1N1) vaccine in various age groups. N. Engl. J. Med. 361:2414-2423. http://dx.doi.org/10.1056/NEJMoa0908535.
10. Holt PG, Jones CA. 2000. The development of the immune system during pregnancy and early life. Allergy 55:688-697. http://dx.doi.org/10.1034/j .1398-9995.2000.00118.x.
11. Wilson CB, Kollmann TR. 2008. Induction of antigen-specific immunity in human neonates and infants. Nestle Nutr. Workshop Ser. Pediatr. Program 61:183-195.
12. PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O, Siegrist CA. 2011. Challenges in infant immunity: implications for responses to infection and vaccines. Nat. Immunol. 12:189-194. http://dx.doi.org/10 .1038/ni0311-189.
13. Marchant A, Goldman M. 2005. T cell-mediated immune responses in human newborns: ready to learn? Clin. Exp. Immunol. 141:10-18. http: //dx.doi.org/10.1111/j.1365-2249.2005.02799.x.
14. Velilla PA, Rugeles MT, Chougnet CA. 2006. Defective antigenpresenting cell function in human neonates. Clin. Immunol. 121:251-259. http://dx.doi.org/10.1016/j.clim.2006.08.010.
15. Granberg C, Hirvonen T, Toivanen P. 1979. Cell-mediated lympholysis by human maternal and neonatal lymphocytes: mother's reactivity against neonatal cells and vice versa. J. Immunol. 123:2563-2567.
16. Wegmann TG, Lin H, Guilbert L, Mosmann TR. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14:353-356. http://dx.doi .org/10.1016/0167-5699(93)90235-D.
17. Firth MA, Shewen PE, Hodgins DC. 2005. Passive and active components of neonatal innate immune defenses. Anim. Health Res. Rev. 6:143-158. http://dx.doi.org/10.1079/AHR2005107.
18. Marodi L. 2006. Innate cellular immune responses in newborns. Clin. Immunol. 118:137-144. http://dx.doi.org/10.1016/j.clim.2005.10.012.
19. Holt PG, Upham JW, Sly PD. 2005. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J. Allergy Clin. Immunol. 116:16-24; quiz 25. http://dx.doi.org/10.1016/j.jaci.2005.04 .017.
20. Haines CJ, Giffon TD, Lu LS, Lu X, Tessier-Lavigne M, Ross DT, Lewis DB. 2009. Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function. J. Exp. Med. 206:275-285. http://dx.doi.org/10.1084/jem.20080996.
21. Hassan J, Reen DJ. 2001. Human recent thymic emigrants-identification, expansion, and survival characteristics. J. Immunol. 167: 1970-1976. http://www.jimmunol.org/content/167/4/1970.long.
22. Bertotto A, Gerli R, Lanfrancone L, Crupi S, Arcangeli C, Cernetti C, Spinozzi F, Rambotti P. 1990. Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody. Cell. Immunol. 127:247-259.
23. Levy O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7:379-390. http://dx.doi.org/10 .1038/nri2075.
24. Vareille M, Kieninger E, Edwards MR, Regamey N. 2011. The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 24:210-229. http://dx.doi.org/10.1128/CMR.00014-10.
25. Burri PH. 1984. Fetal and postnatal development of the lung. Annu. Rev. Physiol. 46:617-628. http://dx.doi.org/10.1146/annurev.ph.46.030184 .003153.
26. Plopper CG, Weir AJ, Nishio SJ, Cranz DL, St George JA. 1986. Tracheal submucosal gland development in the rhesus monkey, Macaca mulatta: ultrastructure and histochemistry. Anat. Embryol. (Berl.) 174:167-178. http://dx.doi.org/10.1007/BF00824332.
27. Van Winkle LS, Fanucchi MV, Miller LA, Baker GL, Gershwin LJ, Schelegle ES, Hyde DM, Evans MJ, Plopper CG. 2004. Epithelial cell distribution and abundance in rhesus monkey airways during postnatal lung growth and development. J. Appl. Physiol. 97:2355-2363; discussion2354. http://dx.doi.org/10.1152/japplphysiol.00470.2004.
28. Yerkovich ST, Wikstrom ME, Suriyaarachchi D, Prescott SL, Upham JW, Holt PG. 2007. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr. Res. 62:547-552. http: //dx.doi.org/10.1203/PDR.0b013e3181568105.
29. Renz H, Brandtzaeg P, Hornef M. 2011. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat. Rev. Immunol. 12:9-23. http://dx.doi.org/10.1038/nri3112.
30. Lotz M, Gutle D, Walther S, Menard S, Bogdan C, Hornef MW. 2006. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 203:973-984. http://dx.doi.org/10.1084/jem.20050625.
31. Maniar-Hew K, Clay CC, Postlethwait EM, Evans MJ, Fontaine JH, Miller LA. 2013. Innate immune response to LPS in airway epithelium is dependent on chronological age and antecedent exposures. Am. J. Respir. Cell Mol. Biol. 49:710-720. http://dx.doi.org/10.1165/rcmb.2012-0321OC.
32. Plopper C, St George J, Cardoso W, Wu R, Pinkerton K, Buckpitt A.1992. Development of airway epithelium. Patterns of expression for markers of differentiation. Chest 101:2S-5S.
33. DeMaria MA, Casto M, O'Connell M, Johnson RP, Rosenzweig M.2000. Characterization of lymphocyte subsets in rhesus macaques during the first year of life. Eur. J. Haematol. 65:245-257. http://dx.doi.org/10 .1034/j.1600-0609.2000.065004245.x.
34. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. Lond. 27:493-497.
35. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, Falcone V, Sorgeloos F, Ehl S, Mayer D, Kochs G, Schwemmle M, Gunther S, Drosten C, Michiels T, Staeheli P. 2010. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84:5670-5677. http://dx.doi.org/10.1128/JVI .00272-10.
36. Khaitov MR, Laza-Stanca V, Edwards MR, Walton RP, Rohde G, Contoli M, Papi A, Stanciu LA, Kotenko SV, Johnston SL. 2009. Respiratory virus induction of alpha-, beta-and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy 64:375-386. http://dx.doi.org/10.1111/j.1398-9995.2008.01826.x.
37. Haye K, Burmakina S, Moran T, Garcia-Sastre A, Fernandez-Sesma A.2009. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J. Virol. 83:6849-6862. http://dx.doi.org/10.1128/JVI.02323-08.
38. Martin-Belmonte F, Puertollano R, Millan J, Alonso MA. 2000. The MAL proteolipid is necessary for the overall apical delivery of membrane proteins in the polarized epithelial Madin-Darby canine kidney and Fischer rat thyroid cell lines. Mol. Biol. Cell 11:2033-2045. http://dx.doi.org /10.1091/mbc.11.6.2033.
39. Frank M. 2000. MAL, a proteolipid in glycosphingolipid enriched domains: functional implications in myelin and beyond. Prog. Neurobiol. 60:531-544. http://dx.doi.org/10.1016/S0301-0082(99)00039-8.
40. Cheong KH, Zacchetti D, Schneeberger EE, Simons K. 1999. VIP17/ MAL, a lipid raft-associated protein, is involved in apical transport in MDCK cells. Proc. Natl. Acad. Sci. U. S. A. 96:6241-6248. http://dx.doi .org/10.1073/pnas.96.11.6241.
41. Marazuela M, Acevedo A, Adrados M, Garcia-Lopez MA, Alonso MA.2003. Expression of MAL, an integral protein component of the machinery for raft-mediated apical transport, in human epithelia. J. Histochem. Cytochem. 51:665-674. http://dx.doi.org/10.1177/002215540305100512.
42. Cao W, Zhang ZY, Xu Q, Sun Q, Yan M, Zhang J, Zhang P, Han ZG, Chen WT. 2010. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma. Mol. Cancer 9:296. http://dx.doi.org/10.1186/1476-4598-9-296.
43. Kollmann TR, Levy O, Montgomery RR, Goriely S. 2012. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 37:771-783. http://dx.doi.org/10.1016/j.immuni .2012.10.014.
44. Josset L, Engelmann F, Haberthur K, Kelly S, Park B, Kawoaka Y, Garcia-Sastre A, Katze MG, Messaoudi I. 2012. Increased viral loads and exacerbated innate host responses in aged macaques infected with the 2009 pandemic H1N1 influenza A virus. J. Virol. 86:11115-11127. http: //dx.doi.org/10.1128/JVI.01571-12.
45. Huang SS, Banner D, Degousee N, Leon AJ, Xu L, Paquette SG, Kanagasabai T, Fang Y, Rubino S, Rubin B, Kelvin DJ, Kelvin AA. 2012. Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection. J. Virol. 86:13187-13201. http://dx.doi.org/10.1128/JVI.01456-12.
46. Carroll TD, Matzinger SR, Genesca M, Fritts L, Colon R, McChesney MB, Miller CJ. 2008. Interferon-induced expression of MxA in the respiratory tract of rhesus macaques is suppressed by influenza virus replication. J. Immunol. 180:2385-2395. http://dx.doi.org/10.4049/jimmunol .180.4.2385.
47. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021-1025. http://dx.doi.org/10.1038/nature08260.
48. Weinfurter JT, Brunner K, Capuano SV, III, Li C, Broman KW, Kawaoka Y, Friedrich TC. 2011. Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS Pathog. 7:e1002381. http://dx.doi.org/10.1371/journal .ppat.1002381.
49. Boonnak K, Paskel M, Matsuoka Y, Vogel L, Subbarao K. 2012. Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in nonhuman primates. Vaccine 30:5603-5610. http://dx.doi.org/10.1016/j .vaccine.2012.06.088.
50. Herfst S, van den Brand JM, Schrauwen EJ, de Wit E, Munster VJ, van Amerongen G, Linster M, Zaaraoui F, van Ijcken WF, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Andeweg AC, Kuiken T. 2010. Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques. Vet. Pathol. 47:1040-1047. http://dx.doi.org/10.1177 /0300985810374836.
51. Oshansky CM, Gartland AJ, Wong SS, Jeevan T, Wang D, Roddam PL, Caniza MA, Hertz T, Devincenzo JP, Webby RJ, Thomas PG. 2014. Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am. J. Respir. Crit. Care Med. 189:449-462. http://dx.doi.org/10.1164/rccm.201309-1616OC.
52. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, Lacasse RA, Kercher L, York A, Korth MJ, Long D, Rosenke R, Shupert WL, Aranda CA, Mattoon JS, Kobasa D, Kobinger G, Li Y, Taubenberger JK, Richt JA, Parnell M, Ebihara H, Kawaoka Y, Katze MG, Feldmann H. 2011. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J. Virol. 85:1214-1223. http://dx.doi.org/10.1128/JVI .01848-10.
53. Fehrenbach H. 2001. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir. Res. 2:33-46. http://dx.doi.org/10.1186/rr36.
54. Kumar PA, Hu Y, Yamamoto Y, Hoe NB, Wei TS, Mu D, Sun Y, Joo LS, Dagher R, Zielonka EM, Wang DY, Lim B, Chow VT, Crum CP, Xian W, McKeon F. 2011. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147:525-538. http://dx.doi.org/10.1016/j.cell.2011.10.001.
55. Nin N, Sanchez-Rodriguez C, Ver LS, Cardinal P, Ferruelo A, Soto L, Deicas A, Campos N, Rocha O, Ceraso DH, El-Assar M, Ortin J, Fernandez-Segoviano P, Esteban A, Lorente JA. 2012. Lung histopathological findings in fatal pandemic influenza A (H1N1). Med. Intensiva 36:24-31. http://dx.doi.org/10.1016/j.medin.2011.10.005.
56. Weinheimer VK, Becher A, Tonnies M, Holland G, Knepper J, Bauer TT, Schneider P, Neudecker J, Ruckert JC, Szymanski K, Temmesfeld-Wollbrueck B, Gruber AD, Bannert N, Suttorp N, Hippenstiel S, Wolff T, Hocke AC. 2012. Influenza A viruses target type II pneumocytes in the human lung. J. Infect. Dis. 206:1685-1694. http://dx.doi.org/10.1093 /infdis/jis455.
57. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. 1997. Influenza virus infections in infants. Pediatr. Infect. Dis. J. 16:1065-1068. http://dx.doi.org/10.1097/00006454-199711000-00012.